We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

June 21, 2017

Omeros Corporation v. Sandoz Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. July 27, 2018

    Sandoz Holds Back On Cataract Drug Generic, Ending IP Suit

    Sandoz Inc. has agreed to hold off on its generic version of Omeros Corp.’s cataract surgery drug Omidria until related patents expire in 15 years, putting an end to infringement litigation in Delaware federal court.


To view the parties, register now.